Default Category
-
Rio Tinto and the Resolution Copper Mining Joint Venture (C): Planning in the Global Financial Crisis
Werhane, Patricia H.; Gorman, Michael E.; Mead, Jenny; Starr, JustinCase DARDEN-E-0375-EBusiness Ethics and Corporate Social ResponsibilityWhen the global recession of 2008–09 hit, Rio Tinto was forced to reexamine its spending priorities. Knowing that the availability of investment capital along with commodity prices would eventually rebound and that project delays could have a negative impact on net present value, David Salisbury and his team were faced with the additional challenge of prioritizing the various aspects of the RCM project. These fell into several categories: (1) rec...Starting at €5.74
-
Rio Tinto and the Resolution Copper Mining Joint Venture (A), (B), and (C) - Teaching Note
Werhane, Patricia H.; Gorman, Michael E.; Mead, Jenny; Starr, JustinTeaching Note DARDEN-E-0373TN-EBusiness Ethics and Corporate Social ResponsibilityTeaching note for product E-0373Starting at €0.00
-
U.S. Universities and Technology Transfer
Hamermesh, Richard G.; Lerner, Josh; Andrews, PhillipCase HBS-812016-EEntrepreneurshipTechnology transfer from U.S. universities to industry has increased dramatically in the last 25 years. Reviews the history of technology transfer with particular emphasis on the Bayh-Dole Act of 1980. It then examines how universities responded to Bayh-Dole, the growth of technology transfer offices, and compares how three different universities (MIT, Stanford, and Harvard) approach technology transfer. Provides an overview of the technology tra...Starting at €8.20
-
Managing Drugs on the Forefront of Personalized Medicine: The Erbitux and Vectibix Story
Hamermesh, Richard G.; Kucherlapati, Raju; Gordon, RachelCase HBS-810066-EEntrepreneurshipIn May 2007, Amgen Inc. (Amgen) received disappointing news from the European Medicines Agency (EMEA) that its drug Vectibix, developed to fight metastatic colorectal cancer, had been rejected. This was especially surprising news given that a similar rival drug had received approval several years prior. Moreover, Vectibix had also received Food and Drug Administration approval in 2006. During additional trials, Amgen has learned that the Vectibix...Starting at €8.20
-
Syndexa and Technology Transfer at Harvard University
Hamermesh, Richard G.; Kiron, DavidCase HBS-808073-EGokhan Hotamisligil is a star researcher at Harvard School of Public Health who has made groundbreaking discoveries linking fat cells, inflammation, and diabetes. He now wants to form a company to commercialize these discoveries. At the same time, Isaac Kohlberg, the head of Harvard's Office of Technology Development (OTD) is eager to improve Harvard's record in commercializing science. Describes the negotiations between Hotamisligil, OTD, the ne...Starting at €8.20
-
The United Fruit Company in Guatemala (Spanish version)
Jones, Geoffrey G.; Bucheli, MarceloCase HBS-807S06EconomicsExamines the overthrow of President Jacobo Arbenz of Guatemala in 1954 in a U.S.-backed coup in support of the United Fruit Co. Over the previous half century, United Fruit had built a large vertically integrated tropical fruit business that owned large banana plantations in the "banana republics" of Central America, including Guatemala. Examines the impact and role of United Fruit in the Guatemalan economy, one of the poorest in the world, and t...Starting at €8.20
-
Global Beauty Made in Brazil (Spanish version)
Jones, Geoffrey G.; Reisen de Pinho, RicardoCase HBS-807S26EntrepreneurshipExplores the globalization strategies of Natura, Brazil's largest cosmetics company. Founded in 1969, Natura grew using a direct selling model. Led by its three founders, the firm made distinctive use of Brazil's diversity and became characterized by high ethical and environmental standards. Natura began to seek international markets in 1982, but experienced many setbacks until surviving the economic crisis in Argentina in 2001. The company opene...Starting at €8.20
-
Note on Managing the Growing Venture (Spanish version)
Hamermesh, Richard G.; Heskett, James L.; Roberts, Michael J.Case HBS-808S03EntrepreneurshipFocuses on the strategic and organizational challenges that confront growing enterprises and the entrepreneurs who lead them. Provides an overview of how a new venture needs to change as it passes from the initial start-up to the growth phase. Explores how a venture's leadership, strategy, and execution need to evolve to deal with rapid growth. A rewritten version of an earlier note.Starting at €8.20
-
Brazil at the Wheel (Spanish Version)
Jones, Geoffrey G.Case HBS-811S19EconomicsSe imparte en el segundo curso de MBA electiva sobre la evolución del Negocio global. Examina los costos y los beneficios de las políticas del gobierno brasileño para fomentar las multinacionales extranjeras para desarrollar una industria del automóvil durante la década de 1950. Una combinación de incentivos y el cierre de mercado se utiliza para atraer la inversión extranjera directa. Volkswagen respondió más positivamente que las empresas estad...Starting at €8.20
-
Lyric Dinner Theater (B) (Spanish version)
Hamermesh, Richard G.; Sharpe, James M.Case HBS-815S17EntrepreneurshipSuplementos el caso (A). Rivka Belzer refleja en los resultados y las medidas adoptadas durante los 12 meses siguientes a su primer 6 meses en el trabajo. Suplementos el caso (A). Rivka Belzer tomó un trabajo en su empresa familiar y trabajó diligentemente durante los primeros 6 meses para convertir el negocio alrededor. Este caso suplementario esboza una serie de decisiones que hizo después de los 6 meses y reporta los resultados financieros un ...Starting at €5.74